ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1.10
-0.17
( -13.39% )
Updated: 05:59:11

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -424k-549k-1.5M-150k-169k0-470k-3.95M
Pre Tax Income -360k-345k-69k-44k-55k99k-470k-3.95M
Net Income -360k-345k-150k-63k-76k139k-470k-3.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -424k-549k-1.5M-150k-169k0-470k-3.95M
EBITDA -424k-549k-1.5M-150k-169k0-470k-3.95M
Year End 30 June 2024 202120222024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -249k-1.57M-7.31M
Pre Tax Income -248k-915k-7.31M
Net Income -248k-996k-7.31M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.042-0.427-0.196
EBIT -249k-1.57M-7.31M
EBITDA -249k-1.57M-7.31M

Your Recent History

Delayed Upgrade Clock